SCHEMBL9944265

SCHEMBL9944265

C/C(=N\OCCc1ccccc1)C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
IDO1 P14902 1/20 0.36
S1PR1 P21453 1/20 0.36
PPARG P37231 2/20 0.36
PPARD Q03181 2/20 0.36
PPARA Q07869 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
FFAR1 O14842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12057080 0.84 NPC1 (0.45) ALDH1A1LMNAMAPK1HTTL3MBTL1
SCHEMBL9944263 0.84 NPC1 (0.45) ALDH1A1LMNAMAPK1HTTL3MBTL1
SCHEMBL14667502 0.83 MAPT (0.46) ALDH1A1TDP1LMNAMAPK1HTT
SCHEMBL9945503 0.79 ALDH1A1 (0.40) ALDH1A1TDP1LMNAMAPK1HTT
SCHEMBL10523818 0.77 ALDH1A1 (0.47) ALDH1A1TDP1LMNAMAPK1L3MBTL1
SCHEMBL10523820 0.77 ALDH1A1 (0.47) ALDH1A1TDP1LMNAMAPK1L3MBTL1
SCHEMBL10773629 0.76 HTR3A (0.50) ALDH1A1TDP1LMNAMAPK1L3MBTL1
SCHEMBL27835726 0.74 PPARG (0.48) ALDH1A1LMNAMAPK1PPARGPPARA
SCHEMBL9944291 0.73 TAAR1 (0.49) ALDH1A1POLBTDP1LMNAMAPK1
SCHEMBL12057065 0.72 SLC6A4 (0.40) LMNATAAR1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772290-B2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same Oscotech Inc. (KR) 2014-07-08 US disclosed
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME OSCOTEC INC. (KR) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME HIF1A, HIF1AN, EGLN3 ALDH1A1 43/4885POLB 1442/4885TDP1 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.